2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- has been researched along with Carcinoma 256, Walker in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastakis, M; Karakiulakis, GD; Maragoudakis, ME; Missirlis, E; Sarmonica, M; Tsopanoglou, N | 1 |
| Karakiulakis, G; Maragoudakis, ME; Missirlis, E | 1 |
2 other study(ies) available for 2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- and Carcinoma 256, Walker
| Article | Year |
|---|---|
Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties.
Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Allantois; Animals; Antineoplastic Agents; Basement Membrane; Bridged-Ring Compounds; Carcinoma 256, Walker; Chick Embryo; Chorion; Collagen; In Vitro Techniques; Male; Neovascularization, Pathologic; Norbornanes; Rats; Thiocarbamates; Thiones; Tumor Cells, Cultured | 1993 |
Antitumor effect of GPA1734 in rat Walker 256 carcinoma.
Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Antineoplastic Agents; Basement Membrane; Body Weight; Carcinoma 256, Walker; Collagen; Injections, Intraperitoneal; Male; Neoplasm Transplantation; Quinolizines; Rats; Rats, Inbred Strains | 1990 |